These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25833646)

  • 1. EU actions to ensure the safety of tattoos and the protection of consumers.
    Rico AM
    Curr Probl Dermatol; 2015; 48():206-9. PubMed ID: 25833646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tattoo ink production and the tattoo business in the US.
    Haugh IM; Laumann SL; Laumann AE
    Curr Probl Dermatol; 2015; 48():248-52. PubMed ID: 25833652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of tattoo-related adverse events by the EU RAPEX system and by national monitoring.
    Verdier C
    Curr Probl Dermatol; 2015; 48():210-7. PubMed ID: 25833647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical purity and toxicology of pigments used in tattoo inks.
    Petersen H; Lewe D
    Curr Probl Dermatol; 2015; 48():136-41. PubMed ID: 25833635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of tattoo inks: Possible options for a common regulatory framework.
    Minghetti P; Musazzi UM; Dorati R; Rocco P
    Sci Total Environ; 2019 Feb; 651(Pt 1):634-637. PubMed ID: 30245419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European landscape of national regulations of tattoo inks and businesses.
    Laux P; Luch A
    Curr Probl Dermatol; 2015; 48():196-200. PubMed ID: 25833644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of European Council resolution ResAP(2008)1 in Italy. National and regional regulation of tattoo practices: diversity and challenges.
    Renzoni A; Pirrera A; Novello F; Diamante MS; Guarino C
    Curr Probl Dermatol; 2015; 48():201-5. PubMed ID: 25833645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seamless prevention of adverse events from tattooing: integrated strategy emphasising the customer-tattooist interaction.
    Serup J
    Curr Probl Dermatol; 2015; 48():236-47. PubMed ID: 25833651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A medical-toxicological view of tattooing.
    Laux P; Tralau T; Tentschert J; Blume A; Dahouk SA; Bäumler W; Bernstein E; Bocca B; Alimonti A; Colebrook H; de Cuyper C; Dähne L; Hauri U; Howard PC; Janssen P; Katz L; Klitzman B; Kluger N; Krutak L; Platzek T; Scott-Lang V; Serup J; Teubner W; Schreiver I; Wilkniß E; Luch A
    Lancet; 2016 Jan; 387(10016):395-402. PubMed ID: 26211826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of studies on microbial contamination of marketed tattoo inks.
    Bonadonna L
    Curr Probl Dermatol; 2015; 48():190-5. PubMed ID: 25833643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making innovative tattoo ink products with improved safety: possible and impossible ingredients in practical usage.
    Dirks M
    Curr Probl Dermatol; 2015; 48():118-27. PubMed ID: 25833633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the limiting of health risks associated with tattooing: whitelists for tattoo pigments and preservatives.
    Blume A; Platzek T; Vieth B; Hutzler C; Luch A
    Curr Probl Dermatol; 2015; 48():185-9. PubMed ID: 25833642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic reactions in red tattoos: Raman spectroscopy for 'fingerprint' detection of chemical risk spectra in tattooed skin and culprit tattoo inks.
    Hutton Carlsen K; Køcks M; Sepehri M; Serup J
    Skin Res Technol; 2016 Nov; 22(4):460-469. PubMed ID: 26991512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tattoos in a dermatological perspective].
    Høgsberg T; O'Goshi K; Serup J
    Ugeskr Laeger; 2011 Jan; 173(1):34-9. PubMed ID: 21199619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacturing of tattoo ink products today and in future: Europe.
    Michel R
    Curr Probl Dermatol; 2015; 48():103-11. PubMed ID: 25833631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The realistic variables underlying true safety in tattoo pigment manufacturing.
    Barth M
    Curr Probl Dermatol; 2015; 48():112-7. PubMed ID: 25833632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of tattoos and permanent make-up: a regulatory view.
    Giulbudagian M; Schreiver I; Singh AV; Laux P; Luch A
    Arch Toxicol; 2020 Feb; 94(2):357-369. PubMed ID: 32030457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of colourants used in tattoo and permanent make-up techniques, legal regulations, health, and psychological aspects of tattooing.
    Charuta A; Wegner R; Charuta KM; Hanusek K; Paziewska A
    Health Sci Rep; 2023 Sep; 6(9):e1360. PubMed ID: 37692794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tattoo ink-related infections--awareness, diagnosis, reporting, and prevention.
    LeBlanc PM; Hollinger KA; Klontz KC
    N Engl J Med; 2012 Sep; 367(11):985-7. PubMed ID: 22913662
    [No Abstract]   [Full Text] [Related]  

  • 20. Tattoo inks: legislation, pigments, metals and chemical analysis.
    Prior G
    Curr Probl Dermatol; 2015; 48():152-7. PubMed ID: 25833637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.